文献速递胸部骨肌技术与安全DR

利用胸部X线摄影与人工神经网络进行骨质疏松精准筛查:OPSCAN随机对照试验

Osteoporotic Precise Screening Using Chest Radiography and Artificial Neural Network: The OPSCAN Randomized Controlled Trial.
PubMed 文献 · Radiology · 2024-01-01

在学术医疗中心开展的随机对照试验纳入40658名40岁以上、2022年1月至12月接受胸部X线摄影且无DXA检查史者,AI模型识别出4912名(12.1%)高风险者并随机分为筛查组与对照组。筛查组接受全额报销的DXA检查,结合常规DXA后筛查组骨质疏松检出率11.1%(272/2456) vs 对照组1.1%(27/2456),OR 11.2(95%CI 7.5,16.7;P<.001)。结论:对AI胸部X线识别的高风险人群提供DXA筛查可有效诊断更多骨质疏松患者。

要点

  • AI模型从40658名胸部X线受检者中识别出12.1%(4912/40658)为骨质疏松高风险。
  • 筛查组骨质疏松检出率11.1%(272/2456) vs 对照组1.1%(27/2456),OR 11.2(95%CI 7.5,16.7)。
  • 筛查组中未符合正式DXA标准者诊断骨质疏松的OR为23.2(95%CI 10.2,53.1),符合者为8.0(95%CI 5.0,12.6)。

核心结论

  • 对AI胸部X线识别的高风险人群提供DXA筛查,可有效诊断更多骨质疏松患者(筛查组272/2456 [11.1%] vs 对照组27/2456 [1.1%];OR 11.2 [95%CI 7.5,16.7];P<.001)。

研究设计与样本

  • 在学术医疗中心开展的随机对照试验(OPSCAN,注册号NCT05721157),纳入40658名40岁及以上、2022年1月至12月接受胸部X线摄影且无DXA检查史者,AI模型识别高风险者4912名(12.1%)并随机分为筛查组2456例(平均年龄71.8岁±11.5[SD];女性1909例)与对照组2456例(平均年龄72.1岁±11.8;女性1872例),筛查组于2023年1月至6月接受全额报销的DXA检查,对照组接受常规诊疗(由医生或患者自行决定DXA检查,无AI干预),采用逻辑回归检验主要结局新发骨质疏松的组间差异。

诊断标准与关键数值

  • 主要结局为新发骨质疏松;筛查组315/2456(12.8%)接受全额报销DXA,其中237/315(75.2%)诊断为新发骨质疏松;结合两组常规诊疗DXA结果后,筛查组骨质疏松检出272/2456(11.1%) vs 对照组27/2456(1.1%),OR 11.2(95%CI 7.5,16.7;P<.001);筛查组中未符合正式DXA标准者诊断骨质疏松的OR为23.2(95%CI 10.2,53.1),符合者为8.0(95%CI 5.0,12.6),交互P=.03。

临床应用与阅片要点

  • 原文结论为对AI胸部X线识别的高风险人群提供DXA筛查可有效诊断更多骨质疏松患者。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

Background Diagnosing osteoporosis is challenging due to its often asymptomatic presentation, which highlights the importance of providing screening for high-risk populations. Purpose To evaluate the effectiveness of dual-energy x-ray absorptiometry (DXA) screening in high-risk patients with osteoporosis identified by an artificial intelligence (AI) model using chest radiographs. Materials and Methods This randomized controlled trial conducted at an academic medical center included participants 40 years of age or older who had undergone chest radiography between January and December 2022 without a history of DXA examination. High-risk participants identified with the AI-enabled chest radiographs were randomly allocated to either a screening group, which was offered fully reimbursed DXA examinations between January and June 2023, or a control group, which received usual care, defined as DXA examination by a physician or patient on their own initiative without AI intervention. A logistic regression was used to test the difference in the primary outcome, new-onset osteoporosis, between the screening and control groups. Results Of the 40 658 enrolled participants, 4912 (12.1%) were identified by the AI model as high risk, with 2456 assigned to the screening group (mean age, 71.8 years ± 11.5 [SD]; 1909 female) and 2456 assigned to the control group (mean age, 72.1 years ± 11.8; 1872 female). A total of 315 of 2456 (12.8%) participants in the screening group underwent fully reimbursed DXA, and 237 of 315 (75.2%) were identified with new-onset osteoporosis. After including DXA results by means of usual care in both screening and control groups, the screening group exhibited higher rates of osteoporosis detection (272 of 2456 [11.1%] vs 27 of 2456 [1.1%]; odds ratio [OR], 11.2 [95% CI: 7.5, 16.7]; P < .001) compared with the control group. The ORs of osteoporosis diagnosis were increased in screening group participants who did not meet formalized criteria for DXA compared with those who did (OR, 23.2 [95% CI: 10.2, 53.1] vs OR, 8.0 [95% CI: 5.0, 12.6]; interactive P = .03). Conclusion Providing DXA screening to a high-risk group identified with AI-enabled chest radiographs can effectively diagnose more patients with osteoporosis. Clinical trial registration no. NCT05721157 © RSNA, 2024 Supplemental material is available for this article. See also the editorial by Smith and Rothenberg in this issue.

来源:Radiology,查看原文。版权归原作者所有。

引用

  1. Lin C, Tsai DJ, Wang CC, et al. Osteoporotic Precise Screening Using Chest Radiography and Artificial Neural Network: The OPSCAN Randomized Controlled Trial. Radiology. 2024. PMID: 38916510. doi:10.1148/radiol.231937

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。